Aspira Women’s Health (NYSE:AWH) Receives New Coverage from Analysts at StockNews.com

Analysts at StockNews.com began coverage on shares of Aspira Women’s Health (NYSE:AWH – Get Rating) in a research note issued on Sunday. The brokerage set a “sell” rating on the stock.

Aspira Women’s Health Stock Performance

Shares of AWH stock opened at $0.40 on Friday. The business’s 50-day moving average price is $0.47. Aspira Women’s Health has a 12-month low of $0.29 and a 12-month high of $1.26. The company has a market capitalization of $49.84 million, a price-to-earnings ratio of -1.48 and a beta of 2.96.

Aspira Women’s Health Company Profile

(Get Rating)

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.